Tactile Systems Technology Inc (TCMD)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $600.58M
Last updated: Nov 17, 2026 at 11:06 AM ET
Tactile Systems Technology Inc (TCMD) Earnings: Report Dates and Results
Tactile Systems Technology (TCMD) is expected to report earnings on Feb 15, 2027. In the quarter ended Sep 30, 2026, Tactile Systems Technology reported EPS of $0.31, above the $0.30 estimate. It beat the EPS estimate in 6 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
TCMD has an expected report date of Feb 15, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 23.9% above the $0.46 reported for the quarter ended Dec 31, 2025.
TCMD Earnings Call
The latest TCMD earnings call transcript on file is labeled 2026Q3.
Read the 2026Q3 transcriptEarnings History
Of the 39 quarters below that had an estimate, TCMD beat 28, missed 10 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $91.86M, up 7.1% from $85.75M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | $0.31 | $0.30 | N/A | +3.33% | Beat | -13.9% | 2 | 0 up, 2 down | Nov 2, 2026 | $91.86M |
| Jun 30, 2026 | $0.34 | $0.14 | N/A | +142.86% | Beat | +142.9% | 2 | 1 up, 0 down | Aug 10, 2026 | $85.70M |
| Mar 31, 2026 | $0.00 | -$0.04 | -$0.08 - $0.01 | +106.00% | Beat | N/A | 2 | 2 up, 0 down | May 4, 2026 | $75.27M |
| Dec 31, 2025 | $0.46 | $0.45 | $0.44 - $0.45 | +3.37% | Beat | +15.9% | 2 | 2 up, 0 down | Feb 17, 2026 | $103.59M |
| Sep 30, 2025 | $0.36 | $0.21 | $0.20 - $0.21 | +71.43% | Beat | +44.0% | 2 | 2 up, 0 down | Nov 3, 2025 | $85.75M |
| Jun 30, 2025 | $0.14 | $0.14 | $0.11 - $0.18 | 0.00% | In line | -30.0% | 2 | 0 up, 2 down | Aug 4, 2025 | $78.91M |
| Mar 31, 2025 | -$0.11 | -$0.06 | -$0.08 - -$0.05 | -83.33% | Miss | N/A | 2 | 0 up, 2 down | May 5, 2025 | $61.27M |
| Dec 31, 2024 | $0.40 | $0.28 | $0.25 - $0.31 | +41.79% | Beat | +13.4% | 2 | 0 up, 2 down | Feb 18, 2025 | $85.58M |
| Sep 30, 2024 | $0.25 | $0.17 | $0.16 - $0.19 | +47.06% | Beat | -70.6% | 5 | 0 up, 0 down | Nov 4, 2024 | $73.09M |
| Jun 30, 2024 | $0.20 | $0.14 | $0.06 - $0.16 | +42.86% | Beat | +400.0% | 4 | 0 up, 0 down | Aug 5, 2024 | $73.22M |
| Mar 31, 2024 | -$0.05 | -$0.01 | N/A | -400.00% | Miss | N/A | 3 | 0 up, 0 down | May 6, 2024 | $61.09M |
| Dec 31, 2023 | $0.35 | $0.19 | $0.14 - $0.32 | +84.21% | Beat | +52.2% | 3 | 0 up, 0 down | Feb 20, 2024 | $77.65M |
| Sep 30, 2023 | $0.85 | $0.02 | N/A | N/A | N/A | +844.4% | 3 | 0 up, 0 down | Nov 6, 2023 | $69.59M |
| Jun 30, 2023 | $0.04 | -$0.02 | -$0.08 - $0.00 | +300.00% | Beat | N/A | 3 | 0 up, 0 down | Aug 7, 2023 | $68.34M |
| Mar 31, 2023 | -$0.03 | -$0.20 | -$0.40 - -$0.13 | +85.00% | Beat | N/A | 4 | 0 up, 0 down | May 8, 2023 | $58.85M |
| Dec 31, 2022 | $0.23 | $0.14 | $0.13 - $0.15 | +64.29% | Beat | N/A | 3 | 0 up, 0 down | Feb 21, 2023 | $73.90M |
| Sep 30, 2022 | $0.09 | -$0.05 | -$0.12 - -$0.05 | +280.00% | Beat | N/A | 4 | 0 up, 0 down | Nov 7, 2022 | $65.26M |
| Jun 30, 2022 | -$0.15 | -$0.07 | -$0.20 - -$0.06 | -114.29% | Miss | -314.3% | 3 | 0 up, 0 down | Aug 1, 2022 | $59.65M |
| Mar 31, 2022 | -$0.42 | -$0.20 | -$0.54 - -$0.16 | -110.00% | Miss | N/A | 4 | 0 up, 0 down | May 2, 2022 | $47.98M |
| Dec 31, 2021 | -$0.28 | $0.05 | -$0.14 - $0.28 | -660.00% | Miss | -150.9% | 5 | 1 up, 0 down | Feb 22, 2022 | $61.73M |
| Sep 30, 2021 | -$0.17 | $0.12 | $0.07 - $0.17 | -241.67% | Miss | -241.7% | 5 | N/A | Nov 8, 2021 | $52.50M |
| Jun 30, 2021 | $0.07 | $0.02 | -$0.05 - $0.10 | +250.00% | Beat | N/A | 5 | N/A | Aug 2, 2021 | $51.06M |
| Mar 31, 2021 | -$0.12 | -$0.19 | -$0.40 - -$0.06 | +36.84% | Beat | N/A | 5 | N/A | May 3, 2021 | $42.77M |
| Dec 31, 2020 | $0.55 | $0.24 | $0.16 - $0.30 | +129.17% | Beat | +111.5% | 6 | N/A | Feb 23, 2021 | $59.24M |
| Sep 30, 2020 | $0.12 | -$0.06 | -$0.25 - $0.13 | +300.00% | Beat | 0.0% | 6 | N/A | Nov 2, 2020 | $49.09M |
| Jun 30, 2020 | -$0.72 | -$0.23 | -$0.40 - -$0.08 | -213.04% | Miss | -614.3% | 7 | N/A | Aug 3, 2020 | $35.12M |
| Mar 31, 2020 | -$0.05 | -$0.02 | -$0.15 - $0.11 | -150.00% | Miss | -162.5% | 7 | N/A | May 4, 2020 | $43.67M |
| Dec 31, 2019 | $0.26 | $0.27 | $0.19 - $0.32 | -3.70% | Miss | +4.0% | 7 | N/A | Feb 26, 2020 | $11.86M |
| Sep 30, 2019 | $0.12 | $0.11 | $0.06 - $0.17 | +9.09% | Beat | +33.3% | 7 | N/A | Nov 4, 2019 | $49.61M |
| Jun 30, 2019 | $0.14 | $0.08 | $0.01 - $0.09 | +75.00% | Beat | +100.0% | 8 | N/A | Aug 5, 2019 | $90.40M |
| Mar 31, 2019 | $0.08 | -$0.06 | -$0.10 - -$0.01 | +233.33% | Beat | N/A | 6 | N/A | May 6, 2019 | $37.62M |
| Dec 31, 2018 | $0.25 | $0.14 | $0.05 - $0.25 | +78.57% | Beat | +108.3% | 7 | N/A | Feb 28, 2019 | $46.45M |
| Sep 30, 2018 | $0.09 | $0.08 | $0.00 - $0.11 | +12.50% | Beat | +28.6% | 7 | N/A | Nov 5, 2018 | $36.32M |
| Jun 30, 2018 | $0.07 | $0.03 | $0.00 - $0.14 | +133.33% | Beat | +75.0% | 7 | N/A | Aug 6, 2018 | $34.13M |
| Mar 31, 2018 | $0.00 | -$0.14 | -$0.20 - -$0.07 | +98.00% | Beat | N/A | 7 | N/A | May 7, 2018 | $26.85M |
| Dec 31, 2017 | $0.12 | $0.13 | $0.10 - $0.16 | -7.69% | Miss | -7.7% | 7 | N/A | Feb 26, 2018 | $34.89M |
| Sep 30, 2017 | $0.07 | $0.05 | $0.02 - $0.07 | +40.00% | Beat | +600.0% | 6 | N/A | Nov 7, 2017 | $28.28M |
| Jun 30, 2017 | $0.04 | $0.01 | -$0.04 - $0.02 | +300.00% | Beat | -42.9% | 4 | N/A | Aug 7, 2017 | $26.26M |
| Mar 31, 2017 | -$0.09 | -$0.16 | N/A | +43.75% | Beat | N/A | N/A | N/A | May 8, 2017 | $19.85M |
| Dec 31, 2016 | $0.13 | $0.04 | N/A | +225.00% | Beat | N/A | N/A | N/A | Feb 27, 2017 | $28.48M |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was $0.85, up 6.6% from the year before. It was $0.21 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | $0.85 | +6.6% |
| Dec 31, 2024 | $0.80 | -34.1% |
| Dec 31, 2023 | $1.21 | N/A |
| Dec 31, 2022 | -$0.25 | N/A |
| Dec 31, 2021 | -$0.50 | N/A |
| Dec 31, 2020 | -$0.10 | -116.7% |
| Dec 31, 2019 | $0.60 | +47.3% |
| Dec 31, 2018 | $0.41 | +190.9% |
| Dec 31, 2017 | $0.14 | -33.3% |
| Dec 31, 2016 | $0.21 | N/A |
Earnings Calls
The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 6,300 words across 8 speakers.
| Call | Period ending | Words | Speakers | Transcript |
|---|---|---|---|---|
| 2026Q3 | Sep 30, 2026 | 6,285 | 8 | |
| 2026Q2 | Jun 30, 2026 | 6,908 | 8 | |
| 2026Q1 | Mar 31, 2026 | 5,660 | 8 | |
| 2025Q4 | Dec 31, 2025 | 6,591 | 8 | |
| 2025Q3 | Sep 30, 2025 | 7,156 | 9 | |
| 2025Q2 | Jun 30, 2025 | 6,876 | 8 | |
| 2025Q1 | Mar 31, 2025 | 7,759 | 8 | |
| 2024Q4 | Dec 31, 2024 | 8,285 | 9 |
2026Q3 Earnings Call
Opening remarks
Sam Bentzinger Investor Relations Good afternoon, and thank you for joining today's call. With me from Tactile Medical's management team are Sheri Dodd, Chief Executive Officer, and Elaine Birkemeyer, Chief Financial Officer. Before we begin, I'd like to remind everyone that our remarks and responses to your questions today may contain forward-looking statements that are based on the current expectations of management and involve inherent risks and uncertainties. This could cause actual results to differ materially from those indicated, including those identified in the Risk Factors section of our annual report on Form 10-K as well as our most recent 10-Q filing to be filed with the Securities and Exchange Commission. Such factors may be updated from time to time in our filings with the SEC, which are available on our website. We undertake no obligation to publicly update or revise our forward-looking statements as a result of new information, future events, or otherwise. This call will also include references to certain financial measures that are not calculated in accordance with generally accepted accounting principles, or GAAP. We generally refer to these as non-GAAP financial measures. Reconciliations of those non-GAAP financial measures to the most comparable measures calculated and presented in accordance with GAAP are available in the earnings press release on the Investor Relations portion of our website. With that, I'll now turn the call over to Sheri.
Sheri Dodd CEO Thanks, Sam. Good afternoon, everyone, and welcome to our third quarter 2026 earnings call. Here with me is Elaine Birkemeyer, our Chief Financial Officer. We delivered total revenue of $91.9 million in Q3, led by 13% year-over-year growth in lymphedema, marking our fifth consecutive quarter of above-market double-digit growth. This consistency demonstrates the durability of our leadership position and the substantial runway created by a market that remains significantly underpenetrated. Airway clearance revenue was $10 million, down year-over-year as anticipated due to the one-time DME inventory transition associated with the launch of our next-generation AffloVest system. The same DME customers we highlighted in Q2 continued to work through temporary excess inventory during Q3. There were no material changes in the underlying dynamics of the business, and we continue to expect airway clearance revenue to improve sequentially in the fourth quarter. Across the portfolio, we continue to balance strong growth in our core lymphedema business with disciplined execution. Gross margin expanded 90 basis points year-over-year in Q3 to 76.7%, contributing to adjusted EBITDA of $14.3 million. This marks the 12th consecutive quarter of year-over-year gross margin expansion. Importantly, we have achieved this sustained improvement while continuing to invest in our product offerings to deliver greater value to patients and providers.
Frequently Asked Questions About TCMD
When is Tactile Systems Technology's next earnings date?
Tactile Systems Technology's next earnings report is expected for Feb 15, 2027.
Did TCMD beat earnings estimates last quarter?
Yes. Tactile Systems Technology reported EPS of $0.31 for the quarter ended Sep 30, 2026, above the $0.30 estimate, a 3.33% surprise.
What EPS do analysts expect from TCMD next quarter?
The consensus EPS estimate for Tactile Systems Technology for the quarter ending Dec 31, 2026 is $0.57 from 6 analysts, with estimates from $0.49 to $0.66.
How often does TCMD beat earnings estimates?
Tactile Systems Technology beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +35.68%.
TCMD pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors